Miromatrix Medical is a life sciences company focused on a technology for bioengineering transplantable organs to help save and improve patients' lives. Co.'s Bioengineered Organ Pipeline includes: MiroliverELAP, which is Co.'s External Liver Assist Product and is designed to provide liver dialysis for acute liver failure patients; Miroliver, which is Co.'s implantable bioengineered liver that intended to treat patients with acute and chronic liver failure in collaboration with the Mayo Clinic; and Mirokidney, which is Co.'s implantable bioengineered kidney that intended to treat patients with end-stage renal disease. We show 11 historical shares outstanding datapoints in our MIRO shares outstanding history coverage, used to compute MIRO market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing MIRO market cap history over the course of time is important for investors
interested in comparing MIRO's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of MIRO versus a peer is one thing; comparing
MIRO market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like MIRO can fluctuate over the course of history.
With this page we aim to empower investors researching MIRO by allowing them to research the MIRO market cap history. |
Free MIRO Email Alerts:
Video: The Importance of Market Cap
